Purpose of review Oral contraceptive pill-induced hypertension (OCPIH) and hypertensive
disorders in pregnancy (HDP) share common risk factors and pathophysiological …

Fructose (FRU) intake has increased dramatically in recent decades with a corresponding
increased incidence of insulin resistance (IR), particularly in young adults. The use of oral …

Adipose dysfunction and inflammation with or without hepatic defects underlie metabolic
obesity. Glutamine (GLU) improves glucoregulation and metabolic indices but its effects on …

Context Little is known about changes in circulating metabolites during the menstrual cycle
and how use of oral contraceptives (OCs) affects these changes. Objectives To study …

Adolescence is a period of continuous development, including the maturation of
endogenous rhythms across systems and timescales. Although, these dynamic changes are …

Compared to age‐matched men, pre‐menopausal women show greater resilience against
cardiovascular disease (CVD), hepatic steatosis, diabetes and obesity–findings that are …

Glycogen and lipid disruptions represent a spectrum of metabolic disorders that are crucial
risk factors for cardiovascular disease in estrogen-progestin oral contraceptive (COC) users …

Context: Studies have shown that cardiac triglyceride accumulation and impaired Na+-K+-
ATPase activity are linked to diabetes-related cardiovascular disease, particularly in women …

Gestational fructose exposure has detrimental health consequences on both the maternal
and fetus or offspring in the early or later life, contributing to epidemic rise in cardiometabolic …

Objective: We tested the hypothesis that glucocorticoid (GC) exposure in female rats would
lead to glucose dysregulation and elevated cardiac inflammatory biomarkers, which are …